心血管疾病中细胞死亡的靶向成像
本文综述了针对心血管疾病中细胞死亡(主要为凋亡,其次为坏死)的非侵入性成像方法,包括分子、核素、光学及磁共振成像技术,这些方法可识别凋亡级联的中间步骤;动物研究显示在多种心血管疾病中有前景,人体研究已证明可行性但临床用途尚无定论,新技术在评估新型治疗干预时追踪凋亡方面具有前景。
要点
- 凋亡是细胞死亡成像最有前景的靶点,因其可能可逆并可能被干预调节。
- 分子、核素、光学或磁共振成像方法可识别凋亡级联的中间步骤。
- 动物研究显示非侵入性成像在多种心血管疾病中有前景,人体研究已证明可行性但临床用途尚无定论。
核心结论
- 凋亡似乎是细胞死亡成像最有前景的靶点,因为其可能可逆并可能被干预调节。
- 动物研究显示非侵入性成像在多种心血管疾病中有前景,人体研究已证明可行性但临床用途尚无定论。
- 新技术在评估新型治疗干预时追踪凋亡方面具有前景。
研究设计与样本
- 综述类文章,检索范围与纳入文献原文未报告。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 人体研究已证明可行性,但临床用途尚无定论。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Cell death is desirable in cancer cells and undesirable in organs with limited regenerative potential, like the heart. Cell death comes in many forms, but only apoptosis and to a lesser degree necrosis is currently relevant to the clinical imager. Noninvasive imaging of cell death is an attractive option to understand pathophysiology, track disease activity, and evaluate response to intervention. Apoptosis seems to be the most promising target for imaging cell death, because it could be reversible and might be modulated with interventions. Molecular, nuclear, optical, or magnetic resonance imaging-based methods have been developed to identify intermediate steps in the apoptosis cascade. Animal studies show promising results for noninvasive imaging in various cardiovascular diseases. Human studies have shown feasibility, but clinical use is yet inconclusive. Newer technologies offer promise, especially for tracking apoptosis in evaluation of novel therapeutic interventions.
引用
- Shekhar A, Heeger P, Reutelingsperger C, et al. Targeted Imaging for Cell Death in Cardiovascular Disorders. JACC Cardiovasc Imaging. 2018. PMID: 29361478. doi:10.1016/j.jcmg.2017.11.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。